✦ LIBER ✦

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

✍ Scribed by Aimery de Gramont; Eric Van Cutsem; Hans-Joachim Schmoll; Josep Tabernero; Stephen Clarke; Malcolm J Moore; David Cunningham; Thomas H Cartwright; J Randolph Hecht; Fernando Rivera; Seock-Ah Im; György Bodoky; Ramon Salazar; Frédérique Maindrault-Goebel; Einat Shacham-Shmueli; Emilio Bajetta; Martina Makrutzki; Aijing Shang; Thierry André; Paulo M Hoff

Book ID: 118262918
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 277 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(12)70509-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant capecitabine and oxaliplatin fo

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

✍ Yung-Jue Bang; Young-Woo Kim; Han-Kwang Yang; Hyun Cheol Chung; Young-Kyu Park; 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 258 KB

S-1 plus oxaliplatin versus capecitabine

S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial

✍ Yong Sang Hong; Young Suk Park; Ho Yeong Lim; Jeeyun Lee; Tae Won Kim; Kyu-pyo K 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 200 KB

Bevacizumab plus paclitaxel versus bevac

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial

✍ Lang, Istvan; Brodowicz, Thomas; Ryvo, Larisa; Kahan, Zsuzsanna; Greil, Richard; 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 420 KB

Addition of cetuximab to oxaliplatin-bas

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

✍ Timothy S Maughan; Richard A Adams; Christopher G Smith; Angela M Meade; Matthew 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 364 KB

617 POSTER Initial safety findings from

617 POSTER Initial safety findings from XELOXA: a randomised phase III trial of capecitabine plus oxaliplatin vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with stage III colon cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 122 KB

6010 A three-arm phase III randomized tr

6010 A three-arm phase III randomized trial of FOLFOX-4 vs. FOLFOX-4 plus bevacizumab vs. XELOX plus bevacizumab in the adjuvant treatment of patients with stage III or high-risk stage II colon cancer: results of the interim safety analysis of the AVANT trial

✍ Hoff, P.; Clarke, S.; Cunningham, D.; Van Cutsem, E.; Moore, M.; Schmoll, H.J.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB